Back to Search
YASAMAN ALAM, M.D.
M.D.
Neurological Surgery Physician
NPI: 1043771090Individual
Specialties, Licenses & Credentials
Student in an Organized Health Care Education/Training Program
Code: 390200000X
Research & Publications (3)
Randomized phase II study of gemcitabine plus cisplatin or carboplatin [corrected], with or without cetuximab, as first-line therapy for patients with advanced or metastatic non small-cell lung cancer.
PMID 18089875·J Clin Oncol·2007
3-trial
Phase II study of vandetanib or placebo in small-cell lung cancer patients after complete or partial response to induction chemotherapy with or without radiation therapy: National Cancer Institute of Canada Clinical Trials Group Study BR.20.
PMID 17878480·J Clin Oncol·2007
3-trial
Human keratinocytes constitutively produce but do not process interleukin-18.
PMID 10951141·Br J Dermatol·2000
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 625 19TH ST S
BIRMINGHAM, AL 35233 - Phone
- (205) 934-3546
Quick Facts
- NPI
- 1043771090
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 2
- Publications
- 3
Are you this provider?
Claim Your Profile